Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alpha and its contribution to autoimmunity.

Carlo Selmi1, Ana Lleo, Massimo Zuin

  • 1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Genome and Biomedical Sciences Facility, 451 E Health Sciences Drive, Suite 6510, Davis, CA 95616, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

The American journal of gastroenterology·2026
Same author

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

From science to public health impact: Enacting the recommendations of the EASL-Lancet Commission on liver health in Europe.

Journal of hepatology·2026
Same author

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

Signal transduction and targeted therapy·2026
Same author

From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis.

European journal of internal medicine·2026
Same author

Understanding the Tumor Microenvironmental Mechanisms Driving Immunotherapy Resistance in Colorectal Cancer Liver Metastases.

Oncology research·2026

Interferon-alpha (IFN-alpha) is implicated in autoimmune diseases like lupus. Research explores how IFN-alpha contributes to immune dysfunction and potential therapeutic strategies for modulating its effects.

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • Interferon-alpha (IFN-alpha) is recognized for its role in autoimmune diseases such as systemic lupus erythematosus (SLE), autoimmune thyroid disease, and type 1 diabetes.
  • IFN-alpha is a common treatment for chronic viral infections like hepatitis C, but has been linked to the development of autoimmune conditions.

Purpose of the Study:

  • To review recent data supporting the role of IFN-alpha in autoimmunity, with a focus on SLE.
  • To explore potential mechanisms by which IFN-alpha contributes to immune dysfunction.
  • To discuss future therapeutic strategies involving IFN-alpha modulation for autoimmune diseases.

Main Methods:

  • Literature review of recent experimental and clinical data.
  • Analysis of known interaction points between IFN-alpha and immune effector cells.

Related Experiment Videos

  • Discussion of pathogenic potential and genetic/environmental factors in autoimmunity.

    • Main Results:

    • IFN-alpha plays a critical role in the pathogenesis and perpetuation of specific autoimmune diseases.
    • Case reports indicate autoimmune conditions can develop during IFN-alpha therapy.
    • Several interaction points between IFN-alpha and immune cells are defined, though their functional consequences are often unclear.

    Conclusions:

    • IFN-alpha is a significant factor in autoimmunity, particularly SLE, and contributes to immune dysfunction through various mechanisms.
    • Genetic and environmental factors are also crucial in the development of autoimmune conditions.
    • Modulating IFN-alpha presents a potential therapeutic avenue for treating autoimmune diseases.